SCIENTURE HOLDINGS, INC. Cash Provided by (Used in) Operating Activities, Discontinued Operations
SCIENTURE HOLDINGS, INC. (SCNX) reported Cash Provided by (Used in) Operating Activities, Discontinued Operations of $0 for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations · last filed 2026-08-13
- SCIENTURE HOLDINGS, INC. cash provided by (used in) operating activities, discontinued operations for the quarter ending 2026-06-30 was $0.00.
- SCIENTURE HOLDINGS, INC. cash provided by (used in) operating activities, discontinued operations for the quarter ending 2026-03-31 was $0.00.
- SCIENTURE HOLDINGS, INC. cash provided by (used in) operating activities, discontinued operations for the quarter ending 2025-12-31 was $0.00.
- SCIENTURE HOLDINGS, INC. cash provided by (used in) operating activities, discontinued operations for the quarter ending 2025-09-30 was $2.80K.
- SCIENTURE HOLDINGS, INC. cash provided by (used in) operating activities, discontinued operations for fiscal 2025 was $2.80K.
- SCIENTURE HOLDINGS, INC. cash provided by (used in) operating activities, discontinued operations for fiscal 2024 was -$979.08K.
- SCIENTURE HOLDINGS, INC. cash provided by (used in) operating activities, discontinued operations for fiscal 2023 was -$5.87M.
- SCIENTURE HOLDINGS, INC. cash provided by (used in) operating activities, discontinued operations for fiscal 2022 was -$1.37M.
| Period end | Cash Provided by (Used in) Operating Activities, Discontinued Operations 3 month | Cash Provided by (Used in) Operating Activities, Discontinued Operations 3 month as first filed | Cash Provided by (Used in) Operating Activities, Discontinued Operations 6 month | Cash Provided by (Used in) Operating Activities, Discontinued Operations 6 month as first filed | Cash Provided by (Used in) Operating Activities, Discontinued Operations 9 month | Cash Provided by (Used in) Operating Activities, Discontinued Operations 9 month as first filed | Cash Provided by (Used in) Operating Activities, Discontinued Operations 12 month | Cash Provided by (Used in) Operating Activities, Discontinued Operations 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-13 | $0.00 10-Q · filed 2026-08-13 | $0.00 derived: sum of 3 quarters · filed 2026-08-13 | $2.80K derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2026-03-31 | $0.00 10-Q · filed 2026-05-15 | $0.00 derived: sum of 2 quarters · filed 2026-05-15 | $2.80K derived: sum of 3 quarters · filed 2026-05-15 | $2.80K derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $2.80K derived: sum of 2 quarters · filed 2026-03-30 | $2.80K derived: sum of 3 quarters · filed 2026-08-13 | $2.80K 10-K · filed 2026-03-30 | ||||
| 2025-09-30 | $2.80K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $2.80K derived: sum of 2 quarters · filed 2026-08-13 | $2.80K 10-Q · filed 2025-11-12 | -$205.62K derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-06-30 | $0.00 10-Q · filed 2026-08-13 | $0.00 10-Q · filed 2026-08-13 | $8.14K 10-Q · filed 2025-08-12 | -$208.42K derived: sum of 3 quarters · filed 2026-08-13 | -$209.27K derived: sum of 4 quarters · filed 2026-08-13 | |||
| 2025-03-31 | $0.00 10-Q · filed 2026-05-15 | -$208.42K derived: sum of 2 quarters · filed 2026-05-15 | -$209.27K derived: sum of 3 quarters · filed 2026-05-15 | -$448.63K derived: sum of 4 quarters · filed 2026-05-15 | ||||
| 2024-12-31 | -$208.42K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | -$209.27K derived: sum of 2 quarters · filed 2026-03-30 | -$448.63K derived: sum of 3 quarters · filed 2026-03-30 | -$979.08K 10-K · filed 2026-03-30 | ||||
| 2024-09-30 | -$848.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$240.21K derived: sum of 2 quarters · filed 2025-11-12 | -$770.65K 10-Q · filed 2025-11-12 | -$7.47M derived: sum of 4 quarters · filed 2025-11-12 | ||||
| 2024-06-30 | -$239.36K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | -$769.80K 10-Q · filed 2025-08-12 | -$7.47M derived: sum of 3 quarters · filed 2025-08-12 | -$7.30M derived: sum of 4 quarters · filed 2025-08-12 | ||||
| 2024-03-31 | -$530.44K 10-Q · filed 2025-05-12 | -$526.94K 10-Q · filed 2024-06-26 | -$7.23M derived: sum of 2 quarters · filed 2025-05-12 | -$7.06M derived: sum of 3 quarters · filed 2025-05-12 | -$6.83M derived: sum of 4 quarters · filed 2025-05-12 | |||
| 2023-12-31 | -$6.70M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-26 | -$6.53M derived: sum of 2 quarters · filed 2025-03-26 | -$6.30M derived: sum of 3 quarters · filed 2025-03-26 | -$5.87M 10-K · filed 2025-03-26 | -$481.18K 10-K · filed 2024-04-22 | |||
| 2023-09-30 | $174.13K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $403.59K derived: sum of 2 quarters · filed 2024-11-06 | $830.64K 10-Q · filed 2024-11-06 | -$593.89K 10-Q · filed 2024-01-16 | $88.09K derived: sum of 4 quarters · filed 2024-11-06 | |||
| 2023-06-30 | $229.46K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | $656.51K 10-Q · filed 2024-08-09 | -$31.63K 10-Q · filed 2023-08-18 | -$86.04K derived: sum of 3 quarters · filed 2024-08-09 | -$710.75K derived: sum of 4 quarters · filed 2024-08-09 | |||
| 2023-03-31 | $427.05K 10-Q · filed 2024-06-26 | -$31.63K 10-Q · filed 2023-05-15 | -$315.50K derived: sum of 2 quarters · filed 2024-06-26 | -$940.21K derived: sum of 3 quarters · filed 2024-06-26 | -$940.21K derived: sum of 4 quarters · filed 2024-06-26 | |||
| 2022-12-31 | -$742.55K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-22 | -$1.37M derived: sum of 2 quarters · filed 2024-04-22 | -$1.37M derived: sum of 3 quarters · filed 2024-04-22 | -$1.37M 10-K · filed 2024-04-22 | ||||
| 2022-09-30 | -$624.71K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-01-16 | -$624.71K derived: sum of 2 quarters · filed 2024-01-16 | -$623.10K 10-Q · filed 2024-01-16 | |||||
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-18 | $1.61K 10-Q · filed 2023-08-18 | ||||||
| 2022-03-31 | $1.61K 10-Q · filed 2023-05-15 | |||||||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-02 | $0.00 derived: sum of 2 quarters · filed 2018-03-02 | $0.00 10-K · filed 2018-03-02 | |||||
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $0.00 10-Q · filed 2017-11-07 | ||||||
| 2017-06-30 | $0.00 10-Q · filed 2017-08-04 | |||||||
| 2016-12-31 | -$383.40K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-02 | -$698.98K derived: sum of 2 quarters · filed 2018-03-02 | -$809.89K 10-K · filed 2018-03-02 | |||||
| 2016-09-30 | -$315.58K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | -$426.48K 10-Q · filed 2017-11-07 | ||||||
| 2016-06-30 | -$110.91K 10-Q · filed 2017-08-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |